Atea Pharmaceuticals, Inc. (AVIR) has a market capitalization of $462.1M and trades at $5.80. The 52-week range is 2.455-6.45.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3, Earnings Per Share (EPS) of $-1.94.
The stock has a beta of 0.16, operates in the Healthcare sector.
